ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Although miR-122-5p and CDC25A have been studied in several malignancies such as hepatocellular carcinoma and acute myeloid leukemia, their coordinated regulatory relationship within the molecular context of BCR::ABL1-positive chronic myeloid leukemia has not been previously characterized.